Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model - European Urology Focus
Richard G. Stock | Long-Term Outcomes of Permanent Brachytherapy
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Case 1: Therapy and Long PSA Doubling Time in nmCRPC
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer | World Journal of Surgical Oncology | Full Text
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinations - Urology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy - Urology
Cancers | Free Full-Text | Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact | HTML
Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer - Advances in Radiation Oncology
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
